Learn About Lung Cancer

The American Cancer Society “New Research” page provides an overview of ongoing advances in lung cancer research, including developments in prevention, early detection, and treatment such as targeted therapies and immunotherapy. It focuses on what is being studied to better understand and manage lung cancer in the future.

The American Cancer Society explains what lung cancer is, how it develops, and the two main types: non-small cell and small cell lung cancer. It also provides a basic overview of how lung cancer starts in the lungs and why early detection is important.

Find clinicatClinicalTrials.gov trials here. database of ongoing and completed lung cancer clinical trials, including studies on new treatments, screening approaches, and prevention strategies. It helps patients and providers learn about current research efforts and potential opportunities to participate in studies.

The Memorial Sloan Kettering Cancer Center page describes clinical trials and research studies related to lung cancer, including screening trials and efforts to improve early detection methods. It explains how clinical trials are used to evaluate new screening approaches and improve outcomes through earlier diagnosis.

The Memorial Sloan Kettering Cancer Center (MSKCC) provides an overview of lung cancer, including signs and symptoms, risk factors, diagnosis, and when to seek care. It is designed to help patients and the public understand how lung cancer presents and is identified, rather than focusing specifically on screening or prevention.

The National Cancer Institute provides detailed information about treatment options for non-small cell lung cancer, including surgery, radiation therapy, chemotherapy, targeted therapy, and immunotherapy. It also explains how treatment decisions are made based on cancer stage and patient factors, along with summaries of evidence-based clinical guidance.

The National Cancer Institute describes treatment options for small cell lung cancer, including chemotherapy, radiation therapy, immunotherapy, and surgery in limited cases. It also explains how treatment approaches vary depending on whether the disease is limited or extensive stage, and summarizes evidence-based care recommendations.

The National Cancer Institute provides information on treatment options for pleuropulmonary blastoma, a rare childhood lung cancer. It outlines approaches such as surgery, chemotherapy, and radiation therapy, and explains how treatment plans are based on tumor type, stage, and risk factors.

The National Cancer Institute describes treatment options for rare tracheobronchial tumors in children, including surgery, radiation therapy, and chemotherapy. It also explains how treatment is individualized based on tumor type, location, and extent of disease.